Skip to content

USANA Health Sciences USNA Revenue recognized that was included in deferred income at the beginning of the period

Revenue recognized that was included in deferred income at the beginning of the period at other companies

NuSkin Enterprises logo
NuSkin EnterprisesNUS

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$394.19M-30.9%
P/E19.7×+8.5×
P/S0.4×-0.2×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityRevenueRecognized.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's revenue recognized that was included in deferred income at the beginning of the period.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's revenue recognized that was included in deferred income at the beginning of the period?
USANA Health Sciences (USNA) reported revenue recognized that was included in deferred income at the beginning of the period of $8.52M in Q1 2026.
How has USANA Health Sciences's revenue recognized that was included in deferred income at the beginning of the period changed year-over-year?
USANA Health Sciences's revenue recognized that was included in deferred income at the beginning of the period decreased by 11.1% year-over-year, from $9.59M to $8.52M.
What is the long-term trend for USANA Health Sciences's revenue recognized that was included in deferred income at the beginning of the period?
Over 3 years (2021 to 2025), USANA Health Sciences's revenue recognized that was included in deferred income at the beginning of the period has grown at a -8.9% compound annual growth rate (CAGR), from $15.95M to $12.05M.
What does revenue recognized that was included in deferred income at the beginning of the period mean?
The amount of revenue recognized during the period that was previously recorded as a contract liability (deferred revenue). This metric tracks the conversion of customer prepayments into realized sales.